Montanaro Lorenzo, Pandolfi Pier Paolo
Cancer Biology and Genetics Program, Department of Pathology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center,New York, New, York 10021, USA.
Cell Cycle. 2004 Nov;3(11):1387-9. doi: 10.4161/cc.3.11.1251. Epub 2004 Nov 21.
The eukaryotic initiation factor 4E (eIF4E) is a key regulator of protein translation whose function is activated by the Akt and Ras proto-oncogenic signal transduction pathways. eIF4E enhances the translation of mRNAs encoding several genes involved in tumorigenesis and acts as a proto-oncogene, in vitro, when overexpressed in immortalized cells. Importantly, eIF4E is frequently found overexpressed in human cancers of multiple histological origins. However, in vivo evidence of the eIF4E neoplastic potential was lacking until now. Here we discuss recent findings that demonstrate eIF4E's oncogenic role in vivo through direct genetic approaches in the mouse, and identify novel oncogenic functions for this initiation factor in cooperative tumorigenesis and response to therapy.
真核生物起始因子4E(eIF4E)是蛋白质翻译的关键调节因子,其功能由Akt和Ras原癌基因信号转导途径激活。当在永生化细胞中过表达时,eIF4E在体外可增强编码多个参与肿瘤发生基因的mRNA的翻译,并作为原癌基因发挥作用。重要的是,在多种组织学来源的人类癌症中经常发现eIF4E过表达。然而,直到现在还缺乏eIF4E肿瘤形成潜力的体内证据。在此,我们讨论最近的研究发现,这些发现通过在小鼠中采用直接遗传学方法证明了eIF4E在体内的致癌作用,并确定了该起始因子在协同肿瘤发生和对治疗的反应中的新致癌功能。